![Douglas Sheehy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Sheehy
Conseiller Juridique Général chez
MIRUM PHARMACEUTICALS, INC.
Profil
Douglas T.
Sheehy is Director at Aimmune Therapeutics UK Ltd. since 2017.
Mr. Sheehy will be Chief Legal Officer & Secretary at Mirum Pharmaceuticals, Inc. starting in 2025.
Formerly, Mr. Sheehy was Executive Director-Legal & Corporate Law at CV Therapeutics, Inc. from 2002 to 2007.
Mr. Sheehy was Secretary & Chief Legal Officer at Sonoma Biotherapeutics, Inc. from 2016 to 2020.
Mr. Sheehy served as Secretary, Chief Administrative Officer & EVP at Codexis, Inc. from 2014 to 2016.
Mr. Sheehy worked as Attorney at Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP from 1995 to 2000.
Mr. Sheehy was Attorney at Brobeck, Phleger & Harrison LLP from 1994 to 1995.
Mr. Sheehy was Secretary & General Counsel at Aimmune Therapeutics, Inc. from 2016 to 2020.
Mr. Sheehy earned a graduate degree from American University Washington College of Law in 1994 and an undergraduate degree from Dartmouth College in 1989.
Postes actifs de Douglas Sheehy
| Sociétés | Poste | Début |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Conseiller Juridique Général | 19/05/2025 |
Aimmune Therapeutics UK Ltd.
 Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 31/03/2017 |
Anciens postes connus de Douglas Sheehy
| Sociétés | Poste | Fin |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Conseiller Juridique Général | 01/12/2020 |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Conseiller Juridique Général | 01/01/2020 |
| CODEXIS, INC. | Directeur Administratif | 01/04/2016 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Conseiller Juridique Général | 01/04/2007 |
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP
 Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/08/2000 |
Formation de Douglas Sheehy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Brobeck, Phleger & Harrison LLP
 Brobeck, Phleger & Harrison LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
American University Washington College of Law
 American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Aimmune Therapeutics UK Ltd.
Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
